PT3606511T - Composição farmacêutica compreendendo mesilato de lenvatinib - Google Patents
Composição farmacêutica compreendendo mesilato de lenvatinibInfo
- Publication number
- PT3606511T PT3606511T PT187139951T PT18713995T PT3606511T PT 3606511 T PT3606511 T PT 3606511T PT 187139951 T PT187139951 T PT 187139951T PT 18713995 T PT18713995 T PT 18713995T PT 3606511 T PT3606511 T PT 3606511T
- Authority
- PT
- Portugal
- Prior art keywords
- pharmaceutical composition
- lenvatinib mesylate
- lenvatinib
- mesylate
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17164761.3A EP3384901A1 (en) | 2017-04-04 | 2017-04-04 | Pharmaceutical composition comprising lenvatinib mesylate |
Publications (1)
Publication Number | Publication Date |
---|---|
PT3606511T true PT3606511T (pt) | 2022-07-22 |
Family
ID=58489241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT187139951T PT3606511T (pt) | 2017-04-04 | 2018-04-04 | Composição farmacêutica compreendendo mesilato de lenvatinib |
Country Status (6)
Country | Link |
---|---|
US (1) | US11911509B2 (pt) |
EP (2) | EP3384901A1 (pt) |
EA (1) | EA201992328A1 (pt) |
ES (1) | ES2923214T3 (pt) |
PT (1) | PT3606511T (pt) |
WO (1) | WO2018185175A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10583133B2 (en) | 2018-03-12 | 2020-03-10 | Shilpa Medicare Limited | Pharmaceutical compositions of lenvatinib |
ES2922903T3 (es) * | 2018-10-04 | 2022-09-21 | Synthon Bv | Composición farmacéutica que comprende sales de lenvatinib |
CN111053772A (zh) * | 2018-10-16 | 2020-04-24 | 四川科伦药物研究院有限公司 | 一种乐伐替尼的药物组合物及其用途 |
WO2021240281A1 (en) * | 2020-05-23 | 2021-12-02 | Shilpa Medicare Limited | Oral liquid formulations of lenvatinib |
EP4147689A1 (en) | 2021-09-13 | 2023-03-15 | Lotus Pharmaceutical Co., Ltd. | Lenvatinib formulation |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60134679D1 (de) | 2000-10-20 | 2008-08-14 | Eisai R&D Man Co Ltd | Stickstoff enthaltende aromatische Heterozyklen |
PT1698623E (pt) | 2003-12-25 | 2015-06-29 | Eisai R&D Man Co Ltd | Cristal de sal de 4-(3-cloro-4-(ciclopropilaminocarbonil)amino fenoxi)-7-metoxi-6-quinolinacarboxamida ou de seu solvato e rocesso para produção destes |
ES2322175T3 (es) | 2004-09-17 | 2009-06-17 | EISAI R&D MANAGEMENT CO., LTD. | Composicion medicinal con estabilidad mejorada y gelificacion reducida. |
CA2597492A1 (en) | 2005-02-10 | 2006-08-17 | Lifecycle Pharma A/S | A stable pharmaceutical composition comprising a fixed dose combination of fenofibrate and an hmg-coa reductase inhibitor |
CN102716490A (zh) | 2005-09-01 | 2012-10-10 | 卫材R&D管理有限公司 | 药物组合物的崩解性的改善方法 |
ME02359B (me) | 2009-08-19 | 2016-06-20 | Eisai R&D Man Co Ltd | Farmaceutska kompozicija koja sadrži derivate hinolina |
WO2017028660A1 (zh) * | 2015-08-17 | 2017-02-23 | 江苏恒瑞医药股份有限公司 | 一种含有喹啉衍生物或其盐的药物组合物 |
DE102015215604A1 (de) | 2015-08-17 | 2017-02-23 | Schaeffler Technologies AG & Co. KG | Stufenlos verstellbares Getriebe (CVT) mit elektronischem Drehmomentfühler, Antriebstrang und Verfahren zum Steuern / Regeln eines stufenlosen Getriebes |
-
2017
- 2017-04-04 EP EP17164761.3A patent/EP3384901A1/en active Pending
-
2018
- 2018-04-04 EP EP18713995.1A patent/EP3606511B1/en active Active
- 2018-04-04 PT PT187139951T patent/PT3606511T/pt unknown
- 2018-04-04 US US16/603,031 patent/US11911509B2/en active Active
- 2018-04-04 WO PCT/EP2018/058629 patent/WO2018185175A1/en unknown
- 2018-04-04 EA EA201992328A patent/EA201992328A1/ru unknown
- 2018-04-04 ES ES18713995T patent/ES2923214T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
EP3606511A1 (en) | 2020-02-12 |
US20200188380A1 (en) | 2020-06-18 |
EA201992328A1 (ru) | 2020-02-14 |
EP3606511B1 (en) | 2022-04-20 |
EP3384901A1 (en) | 2018-10-10 |
US11911509B2 (en) | 2024-02-27 |
WO2018185175A1 (en) | 2018-10-11 |
ES2923214T3 (es) | 2022-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL265360B (en) | Pharmaceutical composition | |
IL271657A (en) | medical preparation | |
IL265260B (en) | pharmaceutical preparations | |
IL269061A (en) | A pharmaceutical preparation containing Selexifag | |
IL271986A (en) | pharmaceutical preparation | |
IL262654A (en) | Pharmacy preparation | |
IL271759B1 (en) | Pharmaceutical preparations that include anthraxtinib | |
IL265349A (en) | Pharmaceutical composition | |
GB201712159D0 (en) | Pharmaceutical composition | |
PT3606511T (pt) | Composição farmacêutica compreendendo mesilato de lenvatinib | |
GB201705303D0 (en) | Pharmaceutical compositions | |
SG11202001179YA (en) | Pharmaceutical compositions | |
IL263040A (en) | Pharmaceutical composition comprising eteplirsen | |
GB201719447D0 (en) | Pharmaceutical composition | |
IL272419A (en) | Pharmaceutical composition | |
GB201705305D0 (en) | Pharmaceutical compositions | |
GB201705304D0 (en) | Pharmaceutical compositions | |
GB201705306D0 (en) | Pharmaceutical compositions | |
GB201615917D0 (en) | Pharmaceutical composition | |
EP3727485C0 (en) | PHARMACEUTICAL COMPOSITION | |
GB201615910D0 (en) | Pharmaceutical composition | |
GB201615914D0 (en) | Pharmaceutical composition | |
IL272044A (en) | Pharmacy preparations | |
HUE057830T2 (hu) | Famitinib tartalmú gyógyszerkészítmény | |
GB201616088D0 (en) | Pharmaceutical composition |